Dashboard
Analysis
Charting
Screener
Resources
Settings
NasdaqGS-ZS
Jul '15
Jul '17
Jan '19
Jul '20
Jan '22
Jul '23
Jan '25
Trailing Valuation
Stock Price
331.1
285.6
226.2
202.6
180.8
179.4
Total Shares Outstanding
159.5
158.3
155.7
154.7
153.4
152.5
Market Cap
52,806.2
45,204.4
35,213.8
31,345.7
27,735.9
27,349.1
Total Enterprise Value (TEV)
51,718.8
43,509.7
33,437
29,703.8
26,265.3
26,177.4
Buyback Yield
-0%
-0.1%
-0.2%
Debt Paydown Yield
—
-1.3%
Shareholder Yield
-1.4%
P/S
18.6
16.9
13.8
12.9
12.1
12.6
P/Gross Profit
24.3
22
17.9
16.6
15.5
16.2
P/E
-1,273.6
-1,057.6
-869.9
-1,841.7
-723.2
-459.9
Earnings Yield
P/OCF
48.5
46.5
38.1
35.3
32.6
35.1
P/FCF
57.1
55.9
45.6
40.7
38.7
43.1
FCF Yield
1.8%
2.2%
2.5%
2.6%
2.3%
P/B
26.6
25.1
19.5
19.4
21.5
EV/Sales
18.3
16.3
13.1
12.3
11.4
EV/Gross Profit
23.8
21.2
17
15.8
14.7
EV/EBITDA
290.6
273.6
230.6
202.2
214.2
292.2
EV/EBIT
-385.5
-338.7
-271.5
-294.8
-247.6
-215.5
EV/OCF
47.5
44.7
36.1
33.5
30.9
33.6
EV/FCF
53.8
43.3
38.5
36.6
41.2
Margins
Gross Profit Margin
76.6%
76.1%
77%
77.1%
77.5%
78%
Operating Margin
-4.6%
-4.5%
-3.7%
-6.2%
-4.9%
EBITDA Margin
6.7%
6.5%
7.3%
4.4%
5.4%
5.5%
Net Profit Margin
-1.5%
-2.4%
-0.6%
-1.2%
-1.9%
-2.5%
Effective Tax Rate
-38.7%
-823.7%
190.4%
53.3%
-173%
-191.5%
Pre-Tax Profit Margin
-1.1%
-0.3%
0.7%
-2.6%
-0.7%
-0.9%
Free Cash Flow Margin
54.7%
26.5%
20.5%
25.4%
50.1%
26%
OCF / Sales
56.9%
34.8%
31.1%
27.7%
52.8%
34.3%
OCF / Net Income
-3,859.5%
-1,425.7%
-5,117.1%
-2,323.1%
-2,749.4%
-1,368.2%
FCF / OCF
96.1%
76%
65.8%
91.6%
94.9%
75.7%
FCF / Net Income
-3,710.5%
-1,084.1%
-3,367.7%
-2,128.6%
-2,608.2%
-1,036.2%
FCF / EBITDA
813.1%
406.2%
281.5%
572.6%
922.7%
468.9%
Capital Efficiency
Return on Invested Capital
-7.1%
0.6%
-2.7%
Return on Assets
-5.4%
0.5%
-0.4%
-2%
Return on Equity
Return on Total Capital
-3.3%
-19.6%
1.9%
-6.8%
-6.4%
Return on Capital Employed
-1.6%
Return on Tangible Assets
Receivables Turnover
1.7
1.1
1.2
1.3
1.6
0.9
Days Sales Outstanding
221.2
337.2
302
280
230
406.1
Payables Turnover
5
4.9
3.8
7.1
5.8
6.2
Days Payables Outstanding
72.9
74.4
96.7
51.3
62.7
58.6
Cash Conversion Cycle
148.3
262.8
205.3
228.7
167.3
347.5
Asset Turnover
0.1
0.2
Fixed Asset Turnover
1.4
1.5
Operating Cycle
CapEx to OCF
0
0.3
CapEx to Revenue
CapEx to Depreciation
0.8
1
Financial Health
Total Debt
1,834
1,796.6
1,228.8
1,238.3
1,237.3
1,238
Net Debt
-1,087.4
-1,694.7
-1,776.8
-1,641.9
-1,470.6
-1,171.7
Current Ratio
1.8
Quick Ratio
Cash Ratio
Debt Ratio
Assets to Equity
3.3
3.6
3
3.1
3.7
Cash Flow to Debt Ratio
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
-714.2
-207.4
380.7
266.6
113.3
-34.2
Goodwill / Assets
Debt / Equity
0.7
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
-20.5
-36.1
-36
-57.2
-43.2
-35.6
EBIT / Interest Expense
-17.1
-15.5
-12.9
-17.2
-9.8
-7.5
EBITDA / Interest Expense
24.9
22.6
10.8
9.1
(EBITDA - Capex) / Interest Expense
16.8
-6.3
-11.6
5.9
5.4
-4.6
Per Share
Revenue per Share
4.6
4.4
4.2
4.1
3.9
Basic EPS
-0.1
-0
Diluted EPS
Book Value per Share
12.5
11.5
11.7
10.5
9.4
8.4
Tangible Book Value per Share
8.5
8.6
7.4
5.2
Cash per Share
18.4
22.3
18.7
17.8
15.9
Operating Cash Flow per Share
2.8
2.2
Free Cash Flow per Share
2.7
2.1
CapEx per Share
0.4
0.5
Weighted Avg. Shares Outstanding
158.6
156.5
154.9
153.7
152.6
151.5
Weighted Avg. Shares Outstanding Diluted
Common Size
R&D to Revenue
24.7%
25%
26.4%
24.6%
23.5%
SG&A to Revenue
55.7%
55.8%
57.8%
59.1%
Stock-based Comp to Revenue
23.9%
24%
26.6%
24.4%
